Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Schmid

Showing results (51-60 of 629) with videos related to

Pageof 63
Sort By:
Therapeutische Umschau. Revue Therapeutique|November 26, 2019
[Allergy assessment: when and how?]Susann Hasler, Eugen Bersuch, Peter Schmid-Grendelmeier
Immunology and Allergy Clinics of North America|November 26, 2016
The Role of Fungi in Atopic DermatitisMartin Glatz, Philipp Bosshard, Peter Schmid-Grendelmeier
Praxis|April 13, 2017
Michael Turgut, Hans-Peter Schmid, Christoph Schwab
Maturitas|October 18, 2011
Nutrition, dietary supplements and adenocarcinoma of the prostateChristopher Schultz, Mark Meier, Hans-Peter Schmid
Therapeutische Umschau. Revue Therapeutique|March 26, 2010
[Atopic dermatitis - current insights into path physiology and management]Peter Schmid-Grendelmeier, Barbara K Ballmer-Weber
Therapeutische Umschau. Revue Therapeutique|October 1, 2025
[Contemporary management of atopic dermatitis: from basic skincare to targeted systemic therapies]Claudia Lang, Matthias Möhrenschlager, Peter Schmid-Grendelmeier
Fortschritte Der Neurologie-Psychiatrie|June 25, 2019
[Consequences of the temporaneous lack of admissibility of involuntary medication in the state of Baden-Wuerttemberg: not less drugs, but longer deprivation of liberty]Tilman Steinert, Simon Keyssner, Peter Schmid, et al.
Urologia Internationalis|July 23, 2008
Growth hormone inhibitors in prostate cancer: a systematic analysisHans-Peter Schmid, Joel Gregorin, Jens E Altwein
World Journal of Urology|February 11, 2021
Reasons to consider prostatic artery embolizationDominik Abt, Hans-Peter Schmid, Mark J Speakman
Healthcare (Basel, Switzerland)|August 29, 2024
Novel Approaches Needed: An Experimental Study with an Alternative to Mechanical RestraintTilman Steinert, Bernd Maierhofer, Peter Schmid, et al.
Pageof 63

Showing results (51-60 of 629) with videos related to

Sort By:
Pageof 63
Therapeutische Umschau. Revue Therapeutique|November 26, 2019
[Allergy assessment: when and how?]Susann Hasler, Eugen Bersuch, Peter Schmid-Grendelmeier
Immunology and Allergy Clinics of North America|November 26, 2016
The Role of Fungi in Atopic DermatitisMartin Glatz, Philipp Bosshard, Peter Schmid-Grendelmeier
Praxis|April 13, 2017
Michael Turgut, Hans-Peter Schmid, Christoph Schwab
Maturitas|October 18, 2011
Nutrition, dietary supplements and adenocarcinoma of the prostateChristopher Schultz, Mark Meier, Hans-Peter Schmid
Therapeutische Umschau. Revue Therapeutique|March 26, 2010
[Atopic dermatitis - current insights into path physiology and management]Peter Schmid-Grendelmeier, Barbara K Ballmer-Weber
Therapeutische Umschau. Revue Therapeutique|October 1, 2025
[Contemporary management of atopic dermatitis: from basic skincare to targeted systemic therapies]Claudia Lang, Matthias Möhrenschlager, Peter Schmid-Grendelmeier
Fortschritte Der Neurologie-Psychiatrie|June 25, 2019
[Consequences of the temporaneous lack of admissibility of involuntary medication in the state of Baden-Wuerttemberg: not less drugs, but longer deprivation of liberty]Tilman Steinert, Simon Keyssner, Peter Schmid, et al.
Urologia Internationalis|July 23, 2008
Growth hormone inhibitors in prostate cancer: a systematic analysisHans-Peter Schmid, Joel Gregorin, Jens E Altwein
World Journal of Urology|February 11, 2021
Reasons to consider prostatic artery embolizationDominik Abt, Hans-Peter Schmid, Mark J Speakman
Healthcare (Basel, Switzerland)|August 29, 2024
Novel Approaches Needed: An Experimental Study with an Alternative to Mechanical RestraintTilman Steinert, Bernd Maierhofer, Peter Schmid, et al.
Pageof 63